Since BCAR3 has been shown to function through Cas to activate c-Src [15], [17], we suggest that its upregulation in triple negative breast cancer cells may contribute to the elevated c-Src activity seen in these tumors. This evidence concerns the gene BCAR3 and triple-negative breast carcinoma.